Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

Receiving a COVID-19 booster vaccine in the same arm as the first vaccine dose leads to a faster, more effective immune ...

A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...

The FDA may be making changes to how it handles COVID-19 booster shots. The agency’s top official says they’re taking a ...

Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...

A Cleveland Clinic web page describing myocarditis survival rates was misrepresented online as news that millions who received COVID-19 vaccines were about to die.

Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

Trinity College Dublin researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended ...

Lawsuit backed by Secretary Kennedy’s former non-profit says CDC is forcing disadvantaged kids to be vaccinated.

CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA ...